VEGF inhibition and renal thrombotic microangiopathy.

By D. Nochy, C. Lefaucheur, G. Hill. New England Journal of Medicine, 2008

876 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). (2016, background): “9, respectively, under bevacizumab, sorafenib and sunitinib.(163,164) A summary of the incidence of hypertension reported in patients with cancer taking these drugs can be found in the appendix at the end of this document.”
Molecular mechanisms of diabetic kidney disease. (2014, unknown): “For example, both increased and decreased VEGF expression causes albuminuria and glomerular changes (57, 58).”
Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. (2010, methodology): “Podo- cin-rtTA ;tetO-Cre mice were provided by S. Quaggin (Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Canada) (49).”
Organotypic vasculature: From descriptive heterogeneity to functional pathophysiology (2017, background): “VEGF blockademay cause proteinuria and thrombotic microangiopathy (126).”